Clinical Trial Update: A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product. [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind trial evaluating the efficacy of an Anserine product for treating hyperuricemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia

Drugs mentioned

• Anserine (anserine)

Snippet

Sponsor: China Medical University Hospital | Conditions: "Hyperuricemia,Anserine" | Phase 2 | Status: UNKNOWN